Skip to content
  • About us
  • For advertising
  • For authors
  • Publishing ethics
  • Contacts
  • GDPR
  • български
Shopping Cart 0
Facebook
GPNews
  • Home
  • IssuesExpand
    • 2025
    • 2024
    • 2023
    • 2022
  • Article summariesExpand
    • AG and Neonatology
    • Allergology
    • Dental Health
    • Cardiology
    • Dermatology and Cosmetics
    • Endocrinology
    • From the Practice
    • Gastroenterology
    • History Teaches
    • In the World of Viruses
    • Nature Teaches
    • Neurology and Psychiatry
    • Nutrition, Dietetics, Metabolism
    • Oncology
    • Ophtalmology
    • Others
    • Otorhinolaryngology and Pulmonary Diseases
    • Pediatrics
    • Rheumatology and Diseases of the Joints
    • Test on a Clinical Case
    • Urology and Nephrology
  • Subscription
Shopping Cart 0
Facebook

  • български

GPNews
Home / Neurology and Psychiatry / Psychedelics in psychiatric practice: psilocybin and esketamine

Psychedelics in psychiatric practice: psilocybin and esketamine

отGP News публикувано на 11.01.202312.01.2023 Neurology and Psychiatry

Issue 1/2023

Marinov1, P., Manolov2, N., Angelova3, A., Koleva4, D.
1 Professor of Psychiatry, Thrace University St. Zagora, MF to SU “St. Kliment Ohridski”
2 M.F. at MU – Sofia, Department of General Medicine
3 freelance psychiatrist
4 general practitioner, “Medic 28”, lecturer at the training base of the Department of General Medicine,
Ministry of Health at the Sofia University

In the last decade the role of psychedelic drugs was reassessed in the treatment of psychiatric disorders. The total number of studies on their efficacy significantly increased. There is a good deal of evidence for the role of esketamine in the treatment of treatment resistant depression. Ayahuaska, psilocybin, LSD and MDMA are also investigated in some psychiatric disorders.

Address for correspondence:
P. Marinov 
Thrace Unviersity St. Zagora
6015, Stara Zagora, University city

Post navigation

Previous Previous
New approach in diagnostics and treatment of schizophrenia: Focus on prepsychotic negative symptoms
NextContinue
Novelties in the strategy and mechanisms of antidepressant therapy
Search
корица 12
All issues in 2023

Issue 12/2023

PULMONOLOGY Current guidelines for the diagnosis and treatment of COPD Yordanov, P., Dimitrova, V. The point of bronchial hyperreactivity (BHR)…

Корица - 112023
All issues in 2023

Issue 11/2023

Ear / Nose / Throat Allergic rhinitis – a risk factor for asthma Perenovska, P. Phenotypes of non allergic rhinitis…

корица 10
All issues in 2023

Issue 10/2023

Endocrinology Carcinogenic risk in obesity and diabetes mellitus Karamfilova, V., Nedeva, I. Anthropometric studies on the effect of yogurt fermented…

fb like

About us

GPNews magazine
A peer of the GP practice in our country
The only specialized edition for general practitioners
12 monthly booklets on topics vital to your practice

Menu

  • Home
  • About us
  • Contact us

Information

  • For authors
  • Publishing ethics
  • For advertising

Copyright © 2025 GPNews. All rights reserved.

Web design and SEO by Tribest

  • GDPR
Scroll to top
  • Home
  • Issues
    • 2025
    • 2024
    • 2023
    • 2022
  • Article summaries
    • AG and Neonatology
    • Allergology
    • Dental Health
    • Cardiology
    • Dermatology and Cosmetics
    • Endocrinology
    • From the Practice
    • Gastroenterology
    • History Teaches
    • In the World of Viruses
    • Nature Teaches
    • Neurology and Psychiatry
    • Nutrition, Dietetics, Metabolism
    • Oncology
    • Ophtalmology
    • Others
    • Otorhinolaryngology and Pulmonary Diseases
    • Pediatrics
    • Rheumatology and Diseases of the Joints
    • Test on a Clinical Case
    • Urology and Nephrology
  • Subscription
  • About us
  • For advertising
  • For authors
  • Publishing ethics
  • Contacts
  • GDPR
Search